Altered SND1-IT1 and miR-494-3p expressions in CHD patients show potential as biomarkers for CHD risk assessment. SND1-IT1 may regulate ox-LDL-induced damage in HUVECs by modulating the interaction between miR-494-3p and ZBTB20.
Song et al. (Tue,) studied this question.